Blood

Blood is the flagship peer-reviewed journal of the American Society of Hematology (ASH), founded in 1946 and published weekly, covering all aspects of hematology, with a 2025 Journal Impact Factor of 23.9《血液》是美国血液学会（American Society of Hematology，ASH）的旗舰同行评审期刊，1946 年创刊并按周出版，涵盖血液学的各个方面，2025 年影响因子为 23.9。

Scope

• It covers all aspects of hematology, including red and white blood cell disorders, both benign and malignant该刊涵盖血液学的各个方面，包括良性与恶性的红细胞与白细胞疾病。
• Its scope extends to platelets, coagulation and other hemostatic mechanisms, and vascular biology其范围还延伸至血小板、凝血及其他止血机制，以及血管生物学。
• It also publishes work in immunology and hematologic oncology, reflecting the breadth of the field该刊亦刊载免疫学与血液肿瘤学的研究，体现该领域的广度。
• All articles undergo a rigorous peer review and are selected for originality, superior quality and clarity of presentation所有文章均经严谨的同行评审，并依原创性、工作质量与表达清晰度择优录用。
• It publishes the original research and reviews central to the understanding and treatment of blood diseases该刊刊载理解与治疗血液疾病所依据的原创研究与综述。^[1]
• It is published weekly in both digital and print form, with 52 issues a year released every Thursday该刊按周以数字版与印刷版出版，每年 52 期，每周四发行。

History

• Blood was first published in January 1946, the brainchild of its founding editor William Dameshek, and 2026 marks its 80th anniversary《血液》于 1946 年 1 月首次出版，由其创始主编 William Dameshek 推动，2026 年为其创刊 80 周年。
• It became the official journal of the American Society of Hematology in 1976, when ASH gained the right to appoint its editors and editorial board该刊于 1976 年成为（American Society of Hematology）的官方期刊，此后该学会取得任命主编与编委会的权力。
• Its editors-in-chief have included Ernst R. Jaffe, John W. Adamson, Arthur W. Nienhuis, James D. Griffin and Nancy Berliner其历任主编包括 Ernst R. Jaffe、John W. Adamson、Arthur W. Nienhuis、James D. Griffin 与 Nancy Berliner。
• Commencing January 1, 2021, ASH began publishing Blood and Blood Advances in partnership with Elsevier自 2021 年 1 月 1 日起，（ASH）与（Elsevier）合作出版《血液》与（Blood Advances）。
• Its digital-only open-access companion journal, Blood Advances, was launched by ASH in 2016其数字版纯开放获取姊妹刊（Blood Advances）由该学会于 2016 年创办。
• Its 2025 Journal Impact Factor is 23.9, ranking second among 103 hematology journals其 2025 年影响因子为 23.9，在 103 种血液学期刊中排名第二。

Editors

• The editor-in-chief is Andrew W. Roberts, MBBS, PhD, of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia现任主编为 Andrew W. Roberts，来自澳大利亚墨尔本的（Walter and Eliza Hall Institute of Medical Research）。
• Deputy editors are Jorge A. Di Paola of the Versiti Blood Research Institute and Helen E. Heslop of Baylor College of Medicine副编辑为（Versiti Blood Research Institute）的 Jorge A. Di Paola 与（Baylor College of Medicine）的 Helen E. Heslop。
• Its associate editors are drawn from leading institutions in the United States, Europe and Asia其助理编辑来自美国、欧洲与亚洲的顶尖机构。
• Roberts succeeded Nancy Berliner, under whom the journal expanded its international editorial boardAndrew W. Roberts 接替 Nancy Berliner 任职，后者任内扩充了该刊的国际编委会。
• The journal maintains an average time to first decision of about 17.5 days该刊初审决定的平均时间约为 17.5 天。
• Every article is peer reviewed and accepted papers appear daily ahead of print as First Edition articles每篇文章均经同行评审，已接收论文每日先以（First Edition）形式在线预发表。